ONC

BeiGene
D

ONC

Arincen62/100B

BeiGene balance sheet 2013–2026

BeiGene had 5.78B USD in cash and short-term investments on 30 September 2026, against total debt of 1.15B USD: net cash of 4.63B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
5.78B4.55B2.63B3.17B3.87B4.38B1.38B618.01M712.94M239.60M87.51M
Short-term investments
0.000.000.002.60M665.25M2.24B3.27B364.73M1.07B597.91M280.66M
5.78B4.55B2.63B3.17B4.53B6.62B4.65B982.74M1.78B837.52M368.17M
Cash growth
+43.21%+73.08%-17.23%-30.00%-31.47%+42.29%+373.24%-44.83%+112.71%+127.48%+266.39%
Receivables
1.15B886.86M709.11M395.89M198.98M500.18M60.40M70.88M49.67M29.43M0.00
Inventory
807.92M608.23M494.99M416.12M282.35M242.63M89.29M28.55M16.24M10.93M0.00
Other current assets
108.70M60.24M25.19M56.25M196.00K328.00K19.58M76.49M17.64M25.73M0.00
Total current assets
7.93B6.23B3.99B4.20B5.21B7.61B4.96B1.17B1.94B913.50M374.40M
Property, plant and equipment
1.80B1.79B1.66B1.37B923.98M662.51M446.30M324.92M194.24M62.57M25.98M
Long-term investments
65.41M82.51M128.93M89.64M91.78M100.79M49.34M0.000.000.000.00
Goodwill and intangibles
37.92M62.70M129.77M108.86M94.57M103.46M53.84M5.96M52.34M19.82M—
Goodwill
—————109.00K109.00K109.00K109.00K109.00K—
Intangible assets
37.92M62.70M129.77M108.86M94.57M103.35M53.73M5.85M52.23M19.72M—
Other non-current assets
44.12M19.91M13.38M31.57M61.89M-55.54M24.62M108.72M29.73M42.92M4.67M
Total assets
9.88B8.19B5.92B5.81B6.38B8.54B5.60B1.61B2.25B1.05B405.81M
Accounts payable
496.88M479.04M405.00M315.11M294.78M262.40M231.96M122.49M113.28M69.78M11.96M
Deferred revenue
0.000.000.000.00213.86M187.41M0.000.0018.14M12.23M0.00
Short-term debt
248.86M134.71M851.53M688.37M328.97M427.57M335.02M0.008.73M9.22M0.00
Other current liabilities
435.95M1.22B359.50M285.81M299.11M260.77M234.57M56.86M31.08M18.99M804.00K
Total current liabilities
2.23B1.83B2.21B1.81B1.47B1.60B1.08B310.31M246.45M149.99M35.06M
Long-term debt
825.22M1.81B166.48M197.62M209.15M202.11M183.64M240.70M189.67M155.49M17.28M
Other non-current liabilities
857.96M51.27M90.70M187.27M187.54M277.44M383.33M57.09M1.08M155.00K564.00K
Lease obligations, current
24.46M0.0017.58M21.95M24.04M21.93M13.90M10.81M0.000.000.00
Lease obligations, long-term
50.22M52.94M44.28M22.25M34.52M43.04M29.42M25.83M0.000.000.00
Total liabilities
4.06B3.83B2.59B2.27B2.00B2.40B1.73B633.93M496.04M362.25M52.91M
Common stock and paid-in capital
148.00K144.00K138.00K135.00K135.00K133.00K118.00K79.00K77.00K59.00K52.00K
Retained earnings
-7.47B-8.32B-8.61B-7.96B-7.08B-5.08B-3.55B-1.96B-1.01B-330.52M-237.41M
Accumulated other comprehensive income
-6.61M-78.18M-148.99M-99.45M-77.42M17.95M6.94M-8.00M1.53M-480.00K-946.00K
Shareholders' equity
5.82B4.36B3.33B3.54B4.38B6.13B3.87B962.21M1.75B684.23M352.91M
Minority interest
0.000.000.000.000.000.000.0016.15M14.45M14.42M0.00
1.15B2.00B1.08B930.19M596.68M694.64M561.96M277.34M198.40M164.72M17.28M
Net cash
4.63B2.55B1.55B2.24B3.94B5.92B4.09B705.40M1.58B672.80M350.89M
Working capital
5.70B4.40B1.78B2.39B3.74B6.01B3.89B862.38M1.70B763.51M339.34M
Book value per share
49.6238.4431.6533.8942.5066.0946.3516.0231.6316.3811.37
Tangible book value
5.78B4.30B3.20B3.43B4.29B6.03B3.82B956.25M1.70B664.41M352.91M
Tangible book value per share
49.2937.8930.4232.8441.5964.9845.7115.9230.6915.9011.37
Current ratio
3.553.411.802.323.554.764.613.787.896.0910.68
Debt to equity
0.200.460.320.260.140.110.150.290.110.240.05

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about BeiGene's cash and debt

Source: Financial Modeling Prep